← Leaderboards
Keiichi Sumida
University Of Tennessee Health Sci Ctr
$3,138,455
Attributed
$3,729,926
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $880.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,729,926 · 2
By mechanism
R01$3,729,926 · 2
Top collaborators
- Susmita Datta3 shared
- Csaba Pal Kovesdy3 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Ankush Gosain$3,243,100
- Karl T Weber$5,639,811
- Ansley Stanfill$1,623,151
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingMicrobialChronic Kidney FailureInflammatoryCardiovascular SystemBiologicalBacterial DnaDialysis ProcedureDna SequencingChronic Inflammatory DiseaseBacterial CommunityBlood CirculationBlood SpecimenBurden Of IllnessBacteriaCohortCathetersArchaeaCharacteristicsChronicCardiovascular DiseasesCardiotoxicityBloodBacterial Translocation
Grant awards (8)
Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial$296,464
R01 · FY2025 · DK · contact PI
Circulating microbiome and premature mortality in hemodialysis patients$359,704
R01 · FY2024 · DK · contact PI
Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial$281,924
R01 · FY2024 · DK · contact PI
Circulating microbiome and premature mortality in hemodialysis patients$572,112
R01 · FY2023 · DK · contact PI
Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial$308,818
R01 · FY2023 · DK · contact PI
Circulating microbiome and premature mortality in hemodialysis patients$594,716
R01 · FY2022 · DK · contact PI
Circulating microbiome and premature mortality in hemodialysis patients$639,117
R01 · FY2021 · DK · contact PI
Circulating microbiome and premature mortality in hemodialysis patients$677,071
R01 · FY2020 · DK · contact PI